Cargando…
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
Autores principales: | Bosetti, Davide Giovanni, Angrisani, Antonio, Castronovo, Francesco Mosè, Pesce, Gianfranco Angelo, Zilli, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643941/ https://www.ncbi.nlm.nih.gov/pubmed/37969364 http://dx.doi.org/10.21037/tcr-23-611 |
Ejemplares similares
-
State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature
por: Le Guevelou, Jennifer, et al.
Publicado: (2023) -
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
por: Ma, Ting Martin, et al.
Publicado: (2021) -
Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014) -
Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial
por: Kishan, Amar U., et al.
Publicado: (2023) -
MicroRNA in radiotherapy: miRage or miRador?
por: Korpela, E, et al.
Publicado: (2015)